Lung Cancer: Screening, Diagnosis and Survival Outcomes
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 3
Special Issue Editor
Interests: lung cancer; precision medicine; immunooncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the evolving landscape of lung cancer, with a focus on innovations and challenges in screening, diagnostic modalities, and survival outcomes. Lung cancer remains the leading cause of cancer-related mortality worldwide, and early detection is critical to improving prognosis. We welcome original research, reviews, and clinical perspectives that address advances in low-dose CT screening, biomarker-driven diagnostics, molecular profiling, and risk stratification strategies. Submissions may also explore disparities in access to screening, novel imaging techniques, and the integration of artificial intelligence in diagnostic workflows. Additionally, we welcome studies that examine treatment outcomes across histologic subtypes, the impact of comorbidities, and real-world survival data in diverse populations. Contributions that highlight multidisciplinary approaches, patient-centered care models, and emerging technologies in early detection and monitoring are encouraged. This Special Issue aims to foster dialogue among clinicians, researchers, and public health experts to advance the field and improve outcomes for patients with lung cancer.
Dr. Nagashree Seetharamu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- screening
- diagnostic modalities
- survival outcomes
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
